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I N T RODUC T I ON
Transient receptor potential melastatin 2 (TRPM2) is 
a Ca2+-permeable cation channel (Perraud et al., 2001; 
Sano et al., 2001), which is activated under conditions 
of oxidative stress (Hara et al., 2002). It is expressed in 
the spleen, bone marrow, leukocytes, pancreatic  cells, 
and most abundantly in the brain (Nagamine et al., 
1998; Perraud et al., 2001; Togashi et al., 2006), and 
plays central roles in chemokine-induced phagocyte 
activation (Yamamoto et al., 2008), insulin secretion 
(Uchida et al., 2011), neuronal apoptosis after cere-
bral stroke (Hara et al., 2002; Kaneko et al., 2006; Olah 
et al., 2009), as well as in the development of several neu-
rodegenerative diseases (Fonfria et al., 2005; Hermosura 
et al., 2008).
TRPM2 channels are homotetramers. In addition to 
a transmembrane domain with a topology conserved 
among all TRP family ion channels and a large N-terminal 
cytosolic region of unknown function, specific to mem-
bers of the TRPM subfamily, TRPM2 contains a unique 
C-terminal NUDT9 homology (NUDT9H) domain, which 
shares 40% sequence identity with the soluble mito-
chondrial enzyme NUDT9 (Perraud et al., 2003a). The 
latter is a specific ADP ribose (ADPR) pyrophosphatase 
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(ADPRase), which cleaves ADPR into AMP and ribose-
5-phosphate (Perraud et al., 2003b). Prompted by this 
sequence homology, TRPM2 channels were discovered 
to be activated by binding, to the NUDT9H domain, of 
ADPR (Perraud et al., 2001; Sano et al., 2001) released 
from mitochondria under conditions of oxidative stress 
(Perraud et al., 2005).
The biophysical mechanism of TRPM2 channel gat-
ing is complex and requires the simultaneous presence 
of micromolar cytosolic Ca2+ and ADPR (McHugh et al., 
2003; Csanády and Törocsik, 2009); some phosphati-
dylinositol 4,5-bisphosphate (PIP2) in the inner mem-
brane leaflet is also essential because after complete 
PIP2 depletion, TRPM2 channels can be opened only in 
the presence of millimolar Ca2+ (Tóth and Csanády, 
2012). The binding sites for activating Ca2+ are un-
known but must be located very near the cytosolic pore 
entrance because they are kept saturated by extracellu-
lar Ca2+ ions entering through the open channel pore 
(Csanády and Törocsik, 2009). However, whereas in 
intact cells TRPM2 channels supply themselves with the 
necessary Ca2+, in excised inside-out patches under con-
tinuous superfusion the high local Ca2+ concentration 
required for TRPM2 gating can be secured only by in-
clusion of high micromolar Ca2+ in the bath solution: 
even millimolar ADPR only marginally activates TRPM2 
channels when (local) intracellular Ca2+ concentration 
Ruling out pyridine dinucleotides as true TRPM2 channel activators 
reveals novel direct agonist ADP-ribose-2-phosphate
Balázs Tóth,1,2 Iordan Iordanov,1,2 and László Csanády1,2
1Department of Medical Biochemistry and 2MTA-SE Ion Channel Research Group, Semmelweis University, 
Budapest H-1094, Hungary
Transient receptor potential melastatin 2 (TRPM2), a Ca2+-permeable cation channel implicated in postischemic 
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420 TRPM2 nucleotide specificity
three compounds as indirect effectors (Tóth and 
Csanády, 2010). Of note, adequate interpretation of 
cADPR effects required prior enzymatic degradation of 
a substantial ADPR contamination detected in commer-
cially available cADPR batches by treatment with a nucle-
otide pyrophosphatase (type I; Sigma-Aldrich) specific to 
linear, as opposed to cyclic, ADPR. Because a similar 
approach for “purifying” linear pyridine dinucleotide 
stocks was not available, it still remains an open question 
as to whether low affinity TRPM2 activation in inside-out 
patches by directly applied NAAD, NAADP (Tóth and 
Csanády, 2010), and NAD (Sano et al., 2001; Hara et al., 
2002) is truly attributable to the pyridine dinucleotides as 
opposed to contaminant ADPR. This question is particu-
larly relevant for the most abundant pyridine dinucleo-
tide NAD, cytosolic concentrations of which are in the 
hundreds-of-micromolar range (Hara et al., 2002).
Here, we take advantage of heterologously expressed 
purified NUDT9 (Tóth et al., 2014), which specifically 
degrades ADPR but not pyridine dinucleotides, to enzy-
matically purify NAD, NAAD, and NAADP from poten-
tial contaminants, and exploit the noninactivating T5L 
TRPM2 variant (Tóth and Csanády, 2012), which allows 
for long steady-state recordings. Our original aim was to 
address the true effect of NAD and its dinucleotide ana-
logues on TRPM2 gating by direct cytosolic application 
of the purified compounds to TRPM2 channels in in-
side-out patches. In addition, our studies led to the for-
tuitous discovery of a novel TRPM2 activator.
MAT E R I A L S  AND  M E THOD S
Molecular biology
T5L-TRPM2/pGEMHE (Tóth and Csanády, 2012) was linearized 
with NheI (New England Biolabs, Inc.) and transcribed in vitro 
using T7 polymerase; cRNA was stored at 80°C.
Isolation and injection of Xenopus laevis oocytes
Xenopus oocytes were dissected, separated by collagenase treat-
ment, and stored at 18°C in a Ringer’s solution supplemented 
with 1.8 mM CaCl2 and 50 µg/ml gentamycin. Oocytes were in-
jected with 10 ng cRNA, and recordings were performed 2–3 d 
after injection.
Excised inside-out patch-clamp recordings
Inward macroscopic TRPM2 channel currents in inside-out 
patches excised from Xenopus oocytes injected with T5L-TRPM2 
cRNA were recorded at a temperature of 25°C in symmetrical Na-
gluconate–based solutions at a membrane potential of 20 mV, 
as described previously (Csanády and Törocsik, 2009). Pipette so-
lution contained (mM): 140 Na-gluconate, 2 Mg-gluconate2, and 
10 HEPES, pH 7.4 with NaOH (free [Ca2+] of 4 µM; the pipette 
electrode was dipped into a 140-mM NaCl-based solution care-
fully layered on top). The continuously flowing bath solution 
(mM: 140 Na-gluconate, 2 Mg-gluconate2, 10 HEPES, pH 7.1 with 
NaOH, and either 1 mM EGTA [to obtain “zero” (8 nM) Ca2+], 
or 1 mM Ca-gluconate2 [to obtain 125 µM free [Ca2+]]) was con-
trolled by electronic valves and could be exchanged with a time 
constant of <100 ms. Na-ADPR (Sigma-Aldrich) was added to the 
is lowered to 1 µM (Tóth and Csanády, 2010). In the 
presence of Ca2+, bursts of channel openings (Csanády 
and Törocsik, 2009) are elicited by mere binding of 
ADPR: a low turnover ADPRase activity reported for the 
isolated NUDT9H domain (Perraud et al., 2001, 2003b) 
was shown not to be coupled to channel gating (Tóth 
et al., 2014). Rapid irreversible inactivation of WT 
TRPM2 channels in inside-out patches is caused by 
a conformational change of the selectivity filter and 
can be overcome by a triple pore substitution: the “T5L” 
TRPM2 variant allows long steady-state recordings while 
preserving all features of WT TRPM2 gating (Tóth and 
Csanády, 2012).
Additional modulators of TRPM2 channel activity 
were identified in numerous studies. In particular, 
hydrogen peroxide (H2O2; Wehage et al., 2002) and 
various adenine nucleotides including cyclic ADPR 
(cADPR; Beck et al., 2006; Lange et al., 2008), nicotin-
amide-adenine-dinucleotide (NAD; Sano et al., 2001; 
Hara et al., 2002), nicotinic acid–adenine-dinucleotide 
(NAAD; Tóth and Csanády, 2010), and NAAD-phos-
phate (NAADP; Beck et al., 2006; Lange et al., 2008; 
Tóth and Csanády, 2010) were all proposed to activate, 
whereas AMP was suggested to inhibit (Kolisek et al., 
2005) TRPM2 channels. Moreover, strongly synergistic 
activation of TRPM2 currents by subthreshold concen-
trations of coapplied ADPR plus cADPR (Kolisek et al., 
2005; Beck et al., 2006; Lange et al., 2008), ADPR plus 
NAADP (Beck et al., 2006; Lange et al., 2008), or ADPR 
plus H2O2 (Kolisek et al., 2005; Lange et al., 2008) out-
lined TRPM2 as a complex molecular machine at the 
crossroads of several signaling pathways, uniquely inte-
grating information from the cell’s redox status as well 
as from several nodes of the adenine nucleotide meta-
bolic network. Given the key role of TRPM2 in a range 
of physiological and pathophysiological processes, it is 
clearly important to identify the precise subset of nucle-
otides that act directly on the channel.
The above conclusions were mostly based on whole-
cell patch-clamp experiments reporting effects on 
TRPM2 currents upon intracellular dialysis of putative 
modulators into intact cells. Because under such condi-
tions the entire cellular machinery for nucleotide me-
tabolism and compartmentalization of both nucleotides 
and Ca2+ are in place, direct effects of a modulator on 
TRPM2 gating cannot be discerned from indirect ef-
fects that modulate TRPM2 activity by changing local 
ADPR and/or Ca2+ concentrations. Moreover, the high 
(typically millimolar) nucleotide concentrations used 
in most studies left room for the possibility that minor 
contaminants in the nucleotide stocks are responsible 
for some of the observed effects. One biophysical study 
in which putative modulators were directly applied to 
the cytosolic face of TRPM2 channels in cell-free inside-
out patches found no direct effect on TRPM2 channel 
gating by H2O2, cADPR, and AMP, classifying these 
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purification followed by gel filtration through a Superdex 200 
10/300 GL column (GE Healthcare). Protein purity was moni-
tored by SDS PAGE, and the final protein concentration was esti-
mated colorimetrically.
Preparation and enzymatic purification of pyridine 
dinucleotide solutions
Sodium salts of NAD, NAAD, and NAADP were purchased from 
Sigma-Aldrich. Stock solutions were prepared at 100–200-mM 
concentrations in water, and the pH was adjusted with NaOH to 
values at which the nucleotides possess no significant buffering 
capacity. To determine such “optimal” target pH values, and the 
stoichiometries of NaOH necessary to achieve them (in the face 
of large variations, among different nucleotides, manufacturers, 
and lot numbers, in sodium content of nucleotide stock pow-
ders), we first obtained complete pH titration curves for a 2-mM 
aqueous solution of each nucleotide batch (Fig. S1). Based on 
these titration curves, target pH was set to 6.5 for NAD (Fig. S1, 
green curve) and to 8.5 for NAAD (Fig. S1, blue curve) and 
NAADP (Fig. S1, purple curves). For the nucleotide batches used 
here, the stoichiometry of NaOH necessary to reach the target pH 
was 0 mol/mol for NAD, 0.85 mol/mol for NAAD, but 2.3 
and 3.1 mol/mol for two different batches of NAADP (Fig. S1).
To purify each dinucleotide from its ADPR or ADPRP contami-
nant, 16 mM MgCl2, 50 mM of either MES, pH 6.5 (for NAD), or 
Tris, pH 8.5 (for NAAD and NAADP), and 1 µM of purified 
NUDT9 were added to the respective pH-adjusted stock solutions, 
and the reaction mixtures were incubated for 2 h at room tem-
perature. Successful clearing of contaminating ADPR or ADPRP 
was monitored by thin-layer chromatography (TLC). For dinucle-
otide/ADPR competition experiments (Fig. 4), the NUDT9 hy-
drolase was removed from purified dinucleotide stock solutions 
by passage through a 5-kD molecular weight cutoff filter (Sarto-
rius), and fractional recovery of dinucleotides was estimated by 
TLC. Solutions containing mixtures of purified, filtered dinucleo-
tides and 1 µM ADPR (Fig. 4) showed no decline, over several 
bath from 32 to 200 mM, and ADPR-2-phosphate (ADPRP; 
Biolog) or nonpurified dinucleotides (Sigma-Aldrich) from 50 to 
200 mM, aqueous stock solutions, followed by adjustment of pH 
to 7.1 using NaOH. The addition of purified dinucleotides (see 
below) to the bath solution caused no significant pH changes 
(<0.1). Currents were amplified and low-pass filtered at 2 kHz, 
digitized at 10 kHz, and stored to disk (Axopatch 200B, Digidata 
1440A, and Pclamp 10; Molecular Devices). For display, currents 
were digitally filtered at 200 Hz.
Data analysis and statistics
Fractional TRPM2 current activation by various concentrations of 
nonpurified and purified pyridine dinucleotides or ADPRP was 
calculated by dividing average steady current in the presence of 
the test nucleotide to the mean of the steady currents recorded in 
the same patch during bracketing applications of 32 µM ADPR, 
all in the presence of saturating (125 µM) cytosolic Ca2+. This 
procedure yields undistorted dose–response relationships, unaf-
fected by the modest time-dependent decline in T5L-TRPM2 
channel activity (see Figs. 1 B, 3, B and C, and 4, B and C), which 
likely reflects gradual depletion of membrane PIP2 (Tóth and 
Csanády, 2012). Dose–response curves were fitted to the Hill 
equation, and macroscopic current relaxation time courses were 
fitted to decaying single-exponential functions, by the method of 
least squares. All data are presented as mean ± SEM from at least 
10 measurements.
Purification of the NUDT9 enzyme
Overexpression and purification of human mitochondrial NUDT9 
hydrolase was done as described previously (Tóth et al., 2014). In 
brief, a synthetic gene of mature NUDT9 (residues 59–350), 
containing a hexahistidine tag at the C terminus and incorpo-
rated into the pJ411 plasmid (DNA2.0), was transformed into 
Escherichia coli (BL21 DE3 strain) and induced with 1 mM IPTG 
for 3 h at 37°C. Cells were harvested and lysed with sonication, 
and the cleared supernatant was subjected to nickel-affinity 
Figure 1. Nonpurified pyridine dinucleotides 
act as low affinity TRPM2 activators. (A–C) Mac-
roscopic T5L-TRPM2 currents elicited in inside-
out patches by cytosolic application of saturating 
(125 µM) Ca2+ (black bars) and either 32 µM 
ADPR (dark blue bars) or increasing concentra-
tions of nonpurified NAD (A, green bars), NAAD 
(B, blue bars), or NAADP (C, purple bars). 
(D) Dose–response curves for fractional current 
activation by ADPR (dark blue; replotted from 
Tóth and Csanády, 2012), and nonpurified NAD 
(green), NAAD (blue), and NAADP (purple). 
Currents were normalized to those measured in 
32 µM ADPR. Solid lines are fits to the Hill equa-
tion yielding K1/2 = 1.4 ± 0.1 µM, n = 1.8 ± 0.2, 
and Irel; = 0.96 ± 0.03 for ADPR; K1/2 = 73 ± 3 µM, 
n = 1.4 ± 0.1, and Irel; = 0.96 ± 0.01 for NAD; 
K1/2 = 109 ± 17 µM, n = 1.3 ± 0.2, and Irel; = 0.96 ± 
0.06 for NAAD; and K1/2 = 226 ± 19 µM, n = 1.8 ± 
0.2, and Irel; = 0.78 ± 0.04 for NAADP. Error bars 
represent mean ± SEM.
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with previous reports (Sano et al., 2001; Hara et al., 
2002; Tóth and Csanády, 2010), all three pyridine di-
nucleotides readily opened TRPM2 channels, but with 
apparent affinities about two orders of magnitude lower 
than for ADPR (Fig. 1 D; fitted K1/2 values were 1.4 ± 0.1 
µM for ADPR [dark blue symbols], 73 ± 3 µM for NAD 
[green symbols], 109 ± 17 µM for NAAD [blue sym-
bols], and 226 ± 19 µM for NAADP [purple symbols]). 
Moreover, whereas TRPM2 channels were fully acti-
vated by saturating concentrations of NAD and NAAD, 
currents in saturating NAADP approached only 78 ± 4% 
of those in 32 µM ADPR (Fig. 1 D, purple fit line).
hours, in their efficiency to cause fractional TRPM2 current acti-
vation, confirming complete removal of the hydrolase by the fil-
tering process (compare Tóth and Csanády, 2010). Purified and 
purified/filtered dinucleotide stocks were stored at 80°C.
TLC
The compositions of nucleotide preparations were verified on ei-
ther Polygram SIL G/UV254 (Macherey-Nagel) or Silica gel 60 F254 
(Merck) TLC plates. Aliquots (1 µl) from each nucleotide sample 
were spotted on the TLC sheet and dried. TLC plates were devel-
oped in 22 different developing solutions, in an attempt to best 
resolve specific components of each particular sample. Develop-
ing solutions used in the figures shown (indicated in the figure 
legends) were DS1 (0.2 M ammonium bicarbonate in water/etha-
nol = 3:7 [vol/vol]), DS2 (3.3 M ammonium formate, 4.2% boric 
acid, pH 7.0 with NH4OH), and DS3 (1 M LiCl, 6% boric acid, 
pH 7.0 with NH4OH). Nucleotides were visualized under UV light.
TLC image processing
All TLC images are presented in grayscale after modification on 
luminosity and contrast for the sole purpose of better visualiza-
tion of weaker spots in the samples. Such adjustments are homog-
enous across each image, and illumination/contrast gradients 
were not used. Some TLC images were vertically split, and the 
lanes are presented in rearranged order for the sake of symmetry 
in sample order.
Mass spectrometry
Electrospray ionization time-of-flight mass spectrometry analysis 
of purified dinucleotide samples was done at the mass spectrom-
etry core facility of the Department of Organic Chemistry, Eötvös 
Loránd University (Budapest, Hungary).
Online supplemental material
Fig. S1 shows pH titration curves of all studied nucleotides, demon-
strating the different pH-buffering capacity and variable sodium 
content of commercial preparations. Fig. S2 demonstrates time-
dependent formation of ADPR from NAD by spontaneous hydroly-
sis in buffered aqueous solutions. Fig. S3 compares chromatographic 
mobilities of nonpurified and purified dinucleotides on nonover-
loaded TLC sheets. The online supplemental material is available 
at http://www.jgp.org/cgi/content/full/jgp.201511377/DC1.
R E S U L T S
Nonpurified pyridine dinucleotides act as low affinity 
TRPM2 activators
To directly compare the potencies and efficacies of 
various pyridine dinucleotides toward stimulation of 
TRPM2 gating, we examined fractional activation of in-
ward macroscopic TRPM2 currents by increasing concen-
trations of NAD (Fig. 1 A, green bars), NAAD (Fig. 1 B, 
blue bars), and NAADP (Fig. 1 C, purple bars), sup-
plied directly to the cytosolic faces of inside-out patches 
excised from Xenopus oocytes expressing human T5L-
TRPM2. All nucleotides were applied in the continued 
presence of saturating (125 µM; compare Tóth and 
Csanády, 2012) cytosolic Ca2+ (Fig. 1, A–C, black bars), 
and activated steady currents were normalized to those 
elicited in the same patch by bracketing exposures 
to saturating (32 µM; compare Tóth and Csanády, 
2012) ADPR (Fig. 1, A–C, dark blue bars). Consistent 
Figure 2. Enzymatic treatment efficiently removes ADPR and 
ADPRP contamination of pyridine dinucleotides. (A–C) TLC im-
ages showing the purification of (A) NAD, (B) NAAD, and (C) 
NAADP. Loaded samples (1 µl) were as follows: (A) 10 mM ADPR 
(lane 1), 10 mM AMP (lane 2), 10 mM NAD (lane 3), and 100 mM 
NAD before (lane 4) and after (lane 5) treatment with NUDT9. 
(B) 10 mM ADPR (lane 1), 10 mM AMP (lane 2), 10 mM NAAD 
(lane 3), and 100 mM NAAD before (lane 4) and after (lane 5) 
treatment with NUDT9. (C) 10 mM NAADP (lane 1), 10 mM 
ADPRP (lane 2), 10 mM AMPP (lane 3), and 100 mM NAADP 
before (lane 4) and after (lane 5) treatment with NUDT9. 
(D) Hydrolytic activity of NUDT9 on ADPR and ADPRP, showing 
10 mM ADPR (lane 1), 10 mM AMP (lane 2), 10 mM ADPR treated 
with NUDT9 (lane 3), 10 mM ADPRP (lane 4), 10 mM AMPP 
(lane 5), 10 mM ADPRP treated with NUDT9 (lane 6), mixture of 
10 mM ADPR and 10 mM ADPRP before (lane 7), and after (lane 
8) treatment with NUDT9. Developing solution was DS2 in A and 
C, and DS1 in B and D.
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prolonged development a previously overlooked faint 
halo becomes discernible at the leading edge of the NAAD 
spot (Fig. 2 B, lane 4). Moreover, that diffuse shadow dis-
appears upon NUDT9 treatment, synchronously with 
the appearance of a novel spot co-migrating with AMP 
(Fig. 2 B, lane 5). These findings confirm that commer-
cial NAAD also contains substantial contamination by 
ADPR, which can be removed by NUDT9 treatment.
Because NAADP and ADPR are well separated in DS1 
developing solution, the lack of an ADPR spot even 
when loading large quantities of NAADP (Tóth and 
Csanády, 2010) suggests that this nucleotide is indeed 
devoid of an ADPR impurity—at least at the level of de-
tection by TLC. One potential source of impurities in 
pyridine dinucleotide stocks might be spontaneous 
cleavage of the pyridine base from the distal ribose. In-
deed, at least in solution and at room temperature, we 
could confirm spontaneous degradation of NAD into 
ADPR over the time course of days (Fig. S2 A), a process 
accelerated at slightly basic pH (Fig. S2 B). If that pro-
cess was indeed the main source of ADPR in our NAD 
and NAAD stocks, this would explain the lack of such 
impurity in NAADP. Because the latter contains an 
additional phosphate at the 2 position of the proxi-
mal ribose, loss of the pyridine base would generate 
ADPRP instead of ADPR. Interestingly, we found that the 
NUDT9 hydrolase also cleaves ADPRP (into AMP-2-
phosphate [AMPP] and ribose-5-phosphate), whether 
Enzymatic treatment efficiently removes ADPR and ADPRP 
contamination of pyridine dinucleotides detectable by TLC
Commercial preparations of NAD were reported 
to contain significant amounts of contaminant ADPR 
(Tóth and Csanády, 2010). To efficiently monitor selec-
tive removal of this contamination by treatment with 
the purified NUDT9 hydrolase, which cleaves ADPR 
into AMP and ribose-5-phosphate (Tóth et al., 2014; 
Fig. 2 D, lanes 1–3; ribose-5-phosphate is not fluo-
rescent and therefore invisible), we used a TLC devel-
oping solution (DS2; see Materials and methods), which 
causes clear separation of all three spots corresponding 
to NAD, ADPR, and AMP (loaded as 1-µl aliquots of 
10-mM solutions; Fig. 2 A, lanes 1–3). Loading a 10-fold 
excess of NAD (Fig. 2 A, lane 4) indeed allowed clear 
detection of a faint spot co-migrating with ADPR; 
NUDT9 treatment eliminated this impurity and caused 
the appearance of a novel spot corresponding to AMP 
(Fig. 2 A, lane 5), confirming stoichiometric cleavage of 
ADPR by the enzyme.
A similarly optimal developing solution was not found 
for NAAD: although DS1 (see Materials and methods) 
causes good separation of NAAD and AMP, even partial 
separation of NAAD from barely faster ADPR requires 
very long runs (Fig. 2 B, lanes 1–3). This might explain 
why ADPR contamination of NAAD was not detected in 
our earlier study using DS1 (Tóth and Csanády, 2010). 
However, when NAAD is loaded at a 10-fold excess, upon 
Figure 3. Purified pyridine dinucleotides 
do not activate TRPM2 channels even at 
very high concentrations. (A–C) Macro-
scopic T5L-TRPM2 currents evoked by 
cytosolic application of saturating Ca2+ 
(black bars) and either 32 µM ADPR (dark 
blue bars) or high concentrations of un-
treated or NUDT9-treated (“purified”) 
NAD (A, green bars), NAAD (B, blue 
bars), or NAADP (C, purple bars). (D) Frac-
tional current activation by indicated 
concentrations (mM) of NUDT9-treated 
(“+”) or nonpurified (“”) NAD (green), 
NAAD (blue), and NAADP (purple). Cur-
rents were normalized to those measured 
in 32 µM ADPR. Error bars represent 
mean ± SEM.
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supporting TRPM2 channel gating. Interestingly, super-
fusion with a bath solution containing saturating Ca2+ 
(Fig. 3, A–C, black bars) and high concentrations of 
purified NAD (Fig. 3 A), NAAD (Fig. 3 B), or NAADP 
(Fig. 3 C) consistently failed to cause TRPM2 channel 
openings in inside-out patches, even though subse-
quent application of the respective nonpurified dinu-
cleotide, or of 32 µM ADPR (Fig. 3, A–C, dark blue 
bars), elicited macroscopic TRPM2 currents in each 
case. Whereas fractional activation by each nonpurified 
dinucleotide (Fig. 3 D, bars labeled “”) conformed to 
that expected from the respective dose–response curve 
(Fig. 1 D), average currents in the presence of each pu-
rified dinucleotide remained identically zero (Fig. 3 D, 
bars labeled “+”). Thus, NAD, NAAD, and NAADP are 
no direct TRPM2 activators.
Purified pyridine dinucleotides do not affect activation  
of TRPM2 channels by subsaturating ADPR
Failure of the pyridine dinucleotides to activate TRPM2 
reflects their inability either to bind to the channel or to 
stabilize the open-pore conformation. In the latter case, 
however, their presence should inhibit TRPM2 activa-
tion by ADPR, by competition for a common binding 
site. To address this possibility, fractional current activa-
tion by a subsaturating concentration of 1 µM ADPR 
alone was compared with that elicited by a mixture 
of 1 µM ADPR and high concentrations of purified 
NAD (Fig. 4 A), NAAD (Fig. 4 B), or NAADP (Fig. 4 C). 
tested in isolation (Fig. 2 D, lanes 4–6) or as a mixture 
with ADPR (Fig. 2 D, lanes 7 and 8). Thus, we reasoned 
that NUDT9 could also be used for the removal of any 
potential ADPRP impurity from NAADP. Indeed, using 
DS2 developing solution, which provides clear separa-
tion of NAADP, ADPRP, and AMPP spots (Fig. 2 C, 
lanes 1–3), loading a 10-fold excess of NAADP reveals 
distinct shadows co-migrating with both ADPRP and 
AMPP (Fig. 2 C, lane 4); the former spot is eliminated 
by NUDT9 treatment, whereas the density of the latter 
spot synchronously increases (Fig. 2 C, lane 5). Thus, 
although NAADP stocks are devoid of ADPR, they 
instead contain ADPRP, which is also removable by 
NUDT9 treatment.
Importantly, as expected, NUDT9 treatment did not 
alter the mobilities of the three pyridine dinucleotides 
(Fig. 2, A–C, lanes 4 and 5; also see Fig. S3 for TLC im-
ages of purified vs. nonpurified dinucleotides without 
overloading), suggesting that NAD, NAAD, and NAADP 
remained intact during the purification procedure, 
a conclusion further confirmed by electrospray ioni-
zation time-of-flight mass spectrometry analysis of the 
purified samples.
Purified pyridine dinucleotides fail to activate TRPM2 
channels even at very high concentrations
Our enzymatically purified pyridine dinucleotide solu-
tions allowed us to address for the first time whether 
the dinucleotides themselves possess any potential for 
Figure 4. Purified pyridine dinucleotides do 
not compete activation of TRPM2 channels 
by ADPR. (A–C) Macroscopic T5L-TRPM2 
currents elicited by cytosolic application of 
saturating Ca2+ (black bars) and either 32 
or 1 µM ADPR (dark blue bars) alone, or a 
mixture of 1 µM ADPR with a high concentra-
tion of NUDT9-treated, filtered (“purified”) 
NAD (A, green bar), NAAD (B, blue bar), or 
NAADP (C, purple bar). (D) Fractional cur-
rent activation by 1 µM ADPR alone (dark 
blue) or in combination with indicated con-
centrations of NUDT9-treated, filtered NAD 
(green), NAAD (blue), and NAADP (purple). 
Currents were normalized to those mea-
sured in 32 µM ADPR. Error bars represent 
mean ± SEM.
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even in saturating ADPRP, TRPM2 currents remained 
distinctly smaller than in 32 µM ADPR (Fig. 5 A). Be-
cause unitary current amplitudes of channels activated 
by ADPR or ADPRP were indistinguishable (1.45 ± 
0.02 pA [n = 5] and 1.45 ± 0.02 pA [n = 5], respec-
tively, at a membrane potential of 20 mV), the reduced 
macroscopic current in ADPRP necessarily reflects a re-
duction in open probability, suggesting that the maxi-
mal efficacy of ADPRP for stimulating channel open 
probability is only 83 ± 2% (Fig. 5 B, red fit line) of that 
of ADPR.
To dissect the kinetic reason for the smaller open 
probability of TRPM2 channels when gated by ADPRP, 
we compared macroscopic current decay rates upon 
sudden removal of activating ADPRP or ADPR in the 
maintained presence of saturating Ca2+ (Fig. 5 C): the 
time constant () of the decaying current is a conve-
nient measure of the average lifetime of a channel open 
burst, elicited by binding of the respective nucleotide 
(Tóth et al., 2014). Time constants of single exponen-
tials fitted to the current decay time courses after 
ADPRP removal (Fig. 5 C, red curves, with  given in 
seconds) were consistently smaller than those obtained 
upon ADPR removal (Fig. 5 C, dark blue curves); on 
average, the estimated mean burst duration of TRPM2 
channels was approximately threefold shorter when they 
were opened by ADPRP as opposed to ADPR (Fig. 5 D, 
compare red and blue bars).
However, fractional currents in 1 µM ADPR (Fig. 4 D, 
dark blue bar) remained unaffected by the presence of 
either dinucleotide (Fig. 4 D, green, blue, and purple 
bars). These results suggest that NAD, NAAD, and 
NAADP fail to activate TRPM2 because they do not fit 
into the ADPR-binding cleft on NUDT9H. They also 
refute a direct mechanism for the reported strong 
positive cooperativity between ADPR and NAADP for 
TRPM2 activation in intact cells (Beck et al., 2006; 
Lange et al., 2008).
ADPRP is a novel true TRPM2 partial agonist with 
distinctive kinetic features
In light of the lack of TRPM2 stimulation by NUDT9-
treated NAADP (Fig. 3 C) and the lack of ADPR con-
tamination in the untreated NAADP stock (Tóth and 
Csanády, 2010), contaminating ADPRP (Fig. 2 C, lane 
4) seemed the most likely candidate responsible for 
TRPM2 stimulation by nonpurified NAADP (Fig. 1 C). 
Indeed, in inside-out patches, in the presence of satu-
rating Ca2+ (Fig. 5 A, black bars), the application of in-
creasing concentrations of ADPRP (Fig. 5 A, red bars) 
activated macroscopic TRPM2 currents in a dose-de-
pendent manner. The dose–response curve for frac-
tional current activation by ADPRP (Fig. 5 B, red 
symbols and fit line) yielded a K1/2 of 13 ± 1 µM, report-
ing an 10-fold lower apparent affinity compared with 
ADPR (Fig. 5 B, dark blue symbols and fit line). Of note, 
Figure 5. ADPRP is a novel true TRPM2 
partial agonist with distinctive kinetic fea-
tures. (A) Macroscopic T5L-TRPM2 cur-
rents in response to cytosolic application 
of saturating Ca2+ (black bars) and either 
32 µM ADPR (dark blue bars) or increas-
ing concentrations of ADPRP (red bars). 
(B) Dose–response curves for fractional 
current activation by ADPR (dark blue; 
replotted from Fig. 1 D) and ADPRP 
(red). Currents were normalized to those 
measured in 32 µM ADPR. Solid lines are 
fits to the Hill equation with parame-
ters plotted in the panel. (C) Macroscopic 
T5L-TRPM2 current repeatedly activated 
by brief exposures to 32 µM ADPR (dark 
blue bars) or 100 µM ADPRP (red bars), in 
the continued presence of saturating Ca2+ 
(black bars). Current decay time courses 
upon nucleotide removal were fitted 
by single-exponential functions (colored 
curves) with time constants indicated (in 
seconds). (D) Average T5L-TRPM2 cur-
rent relaxation time constants (in sec-
onds) upon sudden removal of saturating 
ADPR (dark blue) or ADPRP (red) in the 
maintained presence of Ca2+. Error bars 
represent mean ± SEM.
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a multitude of further adenine nucleotides were screened 
for potential modulatory effects on the channel. These 
studies reported effects on TRPM2 whole-cell currents 
by intracellular dialysis of intact cells with the test com-
pounds. In particular, whereas NADH and NADP were 
found ineffective (Hara et al., 2002), cADPR (Beck et al., 
2006; Lange et al., 2008), NAD (Sano et al., 2001; Hara 
et al., 2002), NAAD (Tóth and Csanády, 2010), and 
NAADP (Beck et al., 2006; Lange et al., 2008; Tóth 
and Csanády, 2010) were all found to activate TRPM2, 
and AMP was proposed to act as an inhibitor (Kolisek 
et al., 2005). Furthermore, strongly synergistic effects 
between ADPR and cADPR (Kolisek et al., 2005; Beck 
et al., 2006; Lange et al., 2008) or ADPR and NAADP 
(Beck et al., 2006; Lange et al., 2008) delineated intri-
cate mechanisms for fine-tuning TRPM2 activity in cells. 
This intriguing position of TRPM2 at the crossroads of 
the complex network of adenine nucleotide metabo-
lism (Malavasi et al., 2008; Koch-Nolte et al., 2009) and 
the multiple roles of TRPM2 in apoptosis (Hara et al., 
2002; Kaneko et al., 2006; Olah et al., 2009), immuno-
cyte activation (Yamamoto et al., 2008), and insulin se-
cretion (Uchida et al., 2011) underscore the importance 
of identifying the precise subset of nucleotides that act 
directly on the TRPM2 protein and their exact effects 
on channel gating.
From the multitude of proposed nucleotide modula-
tors, previous work using direct application to inside-
out patches of AMP and enzymatically purified cADPR 
Kinetic fingerprint betrays active contaminant  
of nonpurified pyridine dinucleotides
If TRPM2 activation by nonpurified pyridine dinucleo-
tides was indeed caused by their ADPR or ADPRP con-
taminations, then the kinetics of gating in each untreated 
dinucleotide should reflect the properties of the respec-
tive contaminant. In particular, macroscopic closing 
rates upon sudden removal of nonpurified dinucleotides 
should betray which of the two contaminants is respon-
sible for channel gating. Indeed, in experiments in which 
macroscopic TRPM2 currents were repeatedly activated 
by brief exposures to saturating concentrations of ADPR 
or various nonpurified pyridine dinucleotides, single-ex-
ponential fits to current decay time courses upon re-
moval of nonpurified NAD (Fig. 6 A, green curves) or 
NAAD (Fig. 6 B, blue curves) yielded time constants (Fig. 6, 
A and B, green and blue numbers) identical to those 
upon removal of ADPR (Fig. 6, A and B, dark blue fit 
lines and numbers; compare Fig. 6 D, left group of bars). 
In contrast, removal of nonpurified NAADP resulted in 
approximately threefold faster current decay (Fig. 6 C, 
purple vs. dark blue curves), with a time constant identi-
cal to that obtained for channel deactivation after re-
moval of ADPRP (Fig. 6 D, purple vs. red bars).
D I S C U S S I ON
Soon after the discovery of ADPR as the primary activa-
tor of TRPM2 (Perraud et al., 2001; Sano et al., 2001), 
Figure 6. Kinetic fingerprint betrays ac-
tive contaminant of nonpurified pyridine 
dinucleotides. (A–C) Macroscopic T5L-
TRPM2 current repeatedly activated by 
brief exposures to 32 µM ADPR (dark 
blue bars) or saturating concentrations of 
nonpurified NAD (1 mM; A, green bars), 
NAAD (1 mM; B, blue bars), or NAADP 
(2 mM; C, purple bars) in the continued 
presence of saturating Ca2+ (black bars). 
Current decay time courses upon nucleotide 
removal were fitted by single-exponential 
functions (colored curves), with time con-
stants indicated (in seconds). (D) Average 
T5L-TRPM2 current relaxation time con-
stants (in seconds) upon sudden removal 
of saturating NAD (green), NAAD (blue), 
or NAADP (purple) in the maintained 
presence of Ca2+. Analogous parameters 
for ADPR (dark blue) and ADPRP (red) 
are replotted from Fig. 5 D for compari-
son. Error bars represent mean ± SEM.
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2011; Fig. 7, left), one probable source of such contami-
nation in commercial preparations is spontaneous 
cleavage of the pyridine base (Fig. S2). We also establish 
here that NUDT9, known as a specific ADPRase (Lin 
et al., 2002), degrades ADPRP as completely as it does 
ADPR (Fig. 7, right; compare Fig. 2 D).
We show here for the first time that pyridine dinucle-
otides themselves are incapable of activating TRPM2 
channels (Fig. 3), even at concentrations orders of mag-
nitude higher than their typical cytosolic values, which 
are submillimolar for NAD (Hara et al., 2002), and 
low nanomolar for NAADP (Churamani et al., 2004; 
Fliegert et al., 2007). In principle, this lack of effect of 
pyridine dinucleotides on TRPM2 might reflect their 
inability either to bind to the NUDT9H domain or to 
promote the conformational change associated with 
pore opening. In the latter case, however, NAD ana-
logues should act as inverse agonists, competing chan-
nel activation by ADPR. Because no such effects could 
be demonstrated for any of the three pyridine dinucleo-
tides tested (Fig. 4), we conclude that NAD, NAAD, and 
NAADP do not activate TRPM2 because they do not 
bind to the NUDT9H domain. Furthermore, because 
none of the dinucleotides caused sensitization toward 
ADPR activation in our cell-free patches (Fig. 4), re-
ported synergistic effects between NAADP and ADPR 
in intact cells (Beck et al., 2006; Lange et al., 2008) must 
firmly ruled out these two nucleotides as direct TRPM2 
effectors (Tóth and Csanády, 2010). In particular, acti-
vation by commercial cADPR was clearly attributable to 
contaminant ADPR, which could be removed by a com-
mercially available nucleotide pyrophosphatase specific 
to linear, as opposed to cyclic, ADPR analogues. Be-
cause efficient tools for purifying linear pyridine dinu-
cleotides were unavailable and ADPR contamination of 
NAAD and NAADP stocks could not be detected, those 
two pyridine dinucleotides were concluded to be low 
affinity direct TRPM2 activators. Recently, we have ex-
pressed and affinity purified NUDT9, a highly specific 
mitochondrial ADPRase (Tóth et al., 2014). Availability 
of this enzyme, combined with cell-free inside-out patch-
clamp technology using rapid direct application of test 
compounds to the cytosolic membrane surface, allowed 
us to address for the first time whether pure pyridine 
dinucleotides can indeed directly interact with, and reg-
ulate gating of, TRPM2 channels.
Using enhanced TLC technology, we demonstrate 
here that commercially available pyridine dinucleotide 
preparations contain significant contamination by the 
respective nucleotide analogue lacking the pyridine 
base (2, 1, and 5%, respectively, in the NAD, NAAD, 
and NAADP batches studied here). Whereas in living 
cells these products, ADPR and ADPRP, are generated 
by the enzyme CD38 (Aarhus et al., 1995; Schmid et al., 
Figure 7. Summary of nucleotide structures and metabolic pathways of interconversion. Color coding: dark blue, ADPR core structure; 
green, nicotinamide; blue, nicotinic acid; red, 2-phosphate. In living cells, ADPR and ADPRP are generated from pyridine dinucleotide 
precursors by the multifunctional enzyme CD38, and degraded into AMP(P) and ribose-5-phosphate by NUDT9. NUDT9 substrates are 
also activators of TRPM2.
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shortened b, without any change in ib, predicts a maxi-
mal Po of 0.64 in ADPRP, which is 77% of that mea-
sured in saturating ADPR and so fully accounts for our 
observations (Fig. 5 B). Thus, just like AMPCPR, ADPRP 
is a partial agonist because it is less efficient than ADPR 
in stabilizing the open (bursting) state. This distinctive 
kinetic fingerprint of ADPRP is also clearly identifiable in 
channels gated by nonpurified NAADP (Fig. 6, C and D).
Our enzymatically purified NAD and NAAD solutions 
also contain the NUDT9 breakdown products AMP and 
ribose-5-P (Fig. 7), and purified NAADP contains AMPP. 
Moreover, if the source of contaminating ADPR(P) is 
indeed spontaneous cleavage of the pyridine base (see 
Fig. S2), then these bases, nicotinamide and nicotinic 
acid (Fig. 7, green and blue), must also be present in 
both our unpurified and purified dinucleotide prepara-
tions. Finally, TLC analysis of various nucleotides in a 
range of different developing solutions revealed other, 
unidentified spots (e.g., in ADPR: Fig. 2 D, lane 1, top; 
in NAADP: Fig. 2 C, lane 4, middle), which resisted 
NUDT9 treatment. However, because all NUDT9-treated 
nucleotides proved inert toward TRPM2, it can be safely 
concluded that neither of ribose-5-P, AMP, AMPP, nico-
tinamide, nicotinic acid, nor any of the unidentified im-
purities directly affect TRPM2 channels (compare Tóth 
and Csanády, 2010).
Besides their physiological implications, our findings 
deepen current understanding of structure–activity re-
lationships in TRPM2 activators (Moreau et al., 2013). 
Specifically, we conclude that a pyridine substitution at 
position 1 of the distal ribose in ADPR (Fig. 7, green 
and blue) is incompatible with NUDT9H binding, whereas 
the presence of a phosphate group at the 2 position of 
the proximal ribose (Fig. 7, red) is tolerated. Further-
more, NUDT9H and NUDT9 appear to possess similar 
substrate specificities: NUDT9 substrates are also TRPM2 
activators, whereas compounds that do not affect TRPM2 
gating are also not substrates for NUDT9.
In conclusion, we have shown here that the pyridine 
dinucleotides NAD, NAAD, and NAADP do not directly 
affect TRPM2 activity, because they are unable to bind 
to the NUDT9H domain. In addition, we have identi-
fied ADPRP as a novel TRPM2 agonist. Further studies 
will have to unravel the in vivo role of ADPRP, as well as 
the relative contributions of ADPR and ADPRP to the 
regulation of TRPM2 activity under various physiologi-
cal and pathophysiological conditions.
This work is supported by an International Early Career Scientist 
grant from the Howard Hughes Medical Institute to L. Csanády, 
and MTA Lendület grant LP2012-39/2012.
The authors declare no competing financial interests.
Sharona E. Gordon served as editor.
Submitted: 2 February 2015
Accepted: 17 March 2015
reflect some indirect effect of NAADP on the local 
concentrations of true TRPM2 agonists. For instance, 
NAADP is a long-known potent Ca2+-mobilizing agent, 
which releases Ca2+ from acidic organelles (Fliegert 
et al., 2007), although its exact molecular target is still 
controversial (Brailoiu et al., 2009; Calcraft et al., 2009, 
but compare Wang et al., 2012). Thus, NAADP might 
modulate TRPM2 activity in cells by elevating local cyto-
solic [Ca2+].
Consistent with spontaneous cleavage of the pyridine 
base as the source of the active contaminant in dinucleo-
tide stocks, our TLC analysis detected ADPRP—but no 
ADPR—contamination in NAADP. Loss of TRPM2 activa-
tion by NAADP upon its enzymatic purification (Fig. 3, C 
and D) strongly suggested that ADPRP might itself act as 
a TRPM2 agonist. Indeed, direct exposure of channels to 
ADPRP effectively stimulated gating (Fig. 5 A). Although 
one might imagine that this stimulation is again caused 
by some minor ADPR contamination of this nucleotide, 
two facts argue against such an interpretation and sug-
gest that ADPRP is itself a direct TRPM2 activator. First, 
to account for the apparent affinity of ADPRP for TRPM2 
activation (K1/2 of 13 µM; Fig. 5 B), only 10-fold lower 
than that of ADPR (K1/2 of 1.4 µM; Fig. 1 D), 10% 
contaminant ADPR in our ADPRP stock would have to 
be postulated. Such a strong contamination would have 
been clearly detectable by TLC but was not observed 
(e.g., Fig. 2 D). Second, the kinetics of channel gating in 
ADPRP was clearly distinct from that in ADPR: compared 
with the latter, ADPRP supported a smaller channel open 
probability even when applied at saturating concentra-
tions, as revealed by maximum currents only 80% of 
those elicited by 32 µM ADPR (Fig. 5, A and B). This 
partial agonist effect of ADPRP, as compared with ADPR, 
was associated with approximately threefold faster clos-
ing rate upon nucleotide removal (Fig. 5, C and D), just 
as reported for the nonhydrolyzable ADPR analogue 
AMPCPR in which the oxygen bridging the two phos-
phates is replaced by a methylene group (Tóth et al., 
2014). The relatively modest depression of open proba-
bility (Po) by a threefold acceleration of closing rate is 
quantitatively explained by the very high Po of TRPM2 in 
saturating ADPR: for T5L-TRPM2 channels gating in 32 
µM ADPR, steady-state single-channel mean open burst 
(b) and closed interburst (ib) durations are 5 and 1 s, 
respectively, and Po is 0.83 (Pob/(b+ib)) (Tóth et al., 
2014). Of note, for both ADPR and AMPCPR, mean 
burst durations were found to be sensitive to nucleotide 
concentration, with steady-state b in saturating nucleo-
tide being substantially longer than the macroscopic 
decay time constant after nucleotide removal (the latter 
reports b in the absence of nucleotide; Tóth et al., 2014). 
Assuming that, for ADPRP, steady-state b in saturating 
nucleotide is similarly shortened as the time constant 
upon its removal (approximately threefold; Fig. 5 D), 
we estimate a b of 1.8 s in saturating ADPRP. This 
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Figure S1. pH titration curves of the five tested nucleotides. Aqueous 2-mM solutions of commercially available nucleotide sodium salts 
were titrated with either NaOH or HCl. Green, NAD (Sigma-Aldrich); blue, NAAD (Sigma-Aldrich), purple, NAADP (Sigma-Aldrich), 
dark blue, ADPR (Sigma-Aldrich); red, ADPRP (Biolog). Note the relative shift between titration curves of two different batches (lot 
numbers) of NAADP, reflecting largely differing Na+ contents of the two commercial stocks.
Figure S2. Spontaneous degradation of NAD in aqueous solution at room temperature. (A and B) 10 mM of enzymatically purified 
NAD in either 50 mM HEPES, pH 7.1 (A), or 50 mM Tris, pH 8.5 (B), was incubated at room temperature, and aliquots were removed 
and frozen at the indicated time points (numbers representing days of incubation); 1 µl of each aliquot was loaded on the TLC sheet. 
“C”, control of 10 mM ADPR in water, freshly thawed from a frozen stock. The AMP spots appear as a result of ADPR hydrolysis during 
the initial enzymatic purification of NAD. Developing solution: DS3 (1 M LiCl and 6% boric acid, pH 7.0 with NH4OH).
S2 TRPM2 nucleotide specificity
Figure S3. Enzymatic purification procedure leaves pyridine dinucleotides intact. (A–C) TLC images showing lack of effect of the en-
zymatic purification procedure on the chromatographic mobilities of (A) NAD, (B) NAAD, and (C) NAADP. Loaded samples (1 µl) were 
as follows: (A and B) 10 mM ADPR (lane 1), 10 mM AMP (lane 2), 10 mM NAD (A) or NAAD (B) before (lane 3) and after (lane 4) 
treatment with NUDT9. (C) 10 mM ADPRP (lane 1), 10 mM AMPP (lane 2), and 10 mM NAADP before (lane 3) and after (lane 4) 
treatment with NUDT9. Developing solution was DS1 in A and B, and DS2 in C.
